Even by conservative assumptions that 5 to 10 per cent of infected individuals develop long Covid, India today may be home to ...

Researchers from the University of Leipzig and Shandong University have recognized GPR133, a receptor in bone-forming cells, ...

Aethlon Medical, Inc. , a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, announced today the 20 November 2025 publication of a pre ...

Aethlon Medical’s Hemopurifier® is an investigational extracorporeal device designed to bind and remove harmful EVs from the ...

Liv Hospital today announced the expansion of its hematology program, offering advanced diagnostic capabilities, specialized ...